comparemela.com

Sierra Capital LLC grew its position in ARK Genomic Revolution ETF (NYSEARCA:ARKG – Get Rating) by 22.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 80,226 shares of the company’s stock after buying an additional 14,669 shares during the quarter. Sierra […]

Related Keywords

,Strategic Blueprint ,Vitalstone Financial ,Sierra Capital ,High Net Worth Advisory Group ,Exchange Commission ,Certified Advisory Corp ,Get Rating ,Advisory Corp ,Net Worth Advisory Group ,Stone Financial ,Visit Holdingschannel ,Ark Genomic Revolution Etf ,Nysearca Arkg ,Darkg ,Nysearca ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.